Cargando…
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) is the most common inherited muscle disease, leading to severe disability and death in young men. Death is caused by the progressive degeneration of striated muscles aggravated by sterile inflammation. The pleiotropic effects of the mutant gene also incl...
Autores principales: | Sinadinos, Anthony, Young, Christopher N. J., Al-Khalidi, Rasha, Teti, Anna, Kalinski, Paweł, Mohamad, Shafini, Floriot, Léonore, Henry, Tiphaine, Tozzi, Gianluca, Jiang, Taiwen, Wurtz, Olivier, Lefebvre, Alexis, Shugay, Mikhail, Tong, Jie, Vaudry, David, Arkle, Stephen, doRego, Jean-Claude, Górecki, Dariusz C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604078/ https://www.ncbi.nlm.nih.gov/pubmed/26461208 http://dx.doi.org/10.1371/journal.pmed.1001888 |
Ejemplares similares
-
Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism
por: Al-Khalidi, Rasha, et al.
Publicado: (2018) -
A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90
por: Young, Christopher NJ, et al.
Publicado: (2015) -
P2RX7 Purinoceptor as a Therapeutic Target—The Second Coming?
por: Young, Chris N. J., et al.
Publicado: (2018) -
P2X7 Purinoceptor Affects Ectopic Calcification of Dystrophic Muscles
por: Rumney, Robin M. H., et al.
Publicado: (2022) -
P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment
por: Young, Christopher N J, et al.
Publicado: (2012)